期刊文献+

Significance of the potential role of pharmacological MRI (phMRI) in diagnosis of Parkinson's disease

Significance of the potential role of pharmacological MRI (phMRI) in diagnosis of Parkinson's disease
原文传递
导出
摘要 The initial diagnosis of Parkinson's disease (PD) is currently based on a clinical assessment. Many patients who receive an initial diagnosis of PD have parkinsonian features related to other diseases such as essential tremor, vascular parkinsonism and atypical parkinsonian disorder. It has been challenging to differentiate PD from those disorders, especially in the early disease stages, due to an overlap of clinical signs and symptoms. Therefore, there is a great need for development of noninvasive, highly sensitive, and widely available imaging methods that can potentially be used to assistant physicians to make more accurate diagnosis of the disease; and to longitudinally monitor treatment of PD. Recent advance of pharmacological MRI (phMRI) technology allows non-invasively mapping functional stages for nigrostriatal dopamine (DA) system. This article aims to review research findings primarily from our group in nonhuman primates modeling the neurodegenerative disease on the value of phMRI techniques in the diagnosis of PD. The initial diagnosis of Parkinson's disease (PD) is currently based on a clinical assessment. Many patients who receive an initial diagnosis of PD have parkinsonian features related to other diseases such as essential tremor, vascular parkinsonism and atypical parkinsonian disorder. It has been challenging to differentiate PD from those disorders, especially in the early disease stages, due to an overlap of clinical signs and symptoms. Therefore, there is a great need for development of noninvasive, highly sensitive, and widely available imaging methods that can potentially be used to assistant physicians to make more accurate diagnosis of the disease; and to longitudinally monitor treatment of PD. Recent advance of pharmacological MRI (phMRI) technology allows non-invasively mapping functional stages for nigrostriatal dopamine (DA) system. This article aims to review research findings primarily from our group in nonhuman primates modeling the neurodegenerative disease on the value of phMRI techniques in the diagnosis of PD.
出处 《Frontiers in Biology》 CAS CSCD 2012年第4期307-312,共6页 生物学前沿(英文版)
关键词 pharmacological MRI (phMRI) Parkinson's disease phMRI techniques pharmacological MRI (phMRI), Parkinson's disease, phMRI techniques
  • 相关文献

参考文献21

  • 1Andersen A H,Zhang Z,Barber T,Rayens W S Zhang J Grondin R Hardy P Gerhardt G A Gash D M. Functional MRI studies in awake rhesus monkeys:methodological and analytical strategies[J].Journal of Neuroscience Methods,2002,(02):141-152.
  • 2Arthurs O J,Boniface S. How well do we understand the neural origins of the fMRI BOLD signal[J].Trends in Neurosciences,2002,(01):27-31.
  • 3Braak H,Del Tredici K. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered[J].Experimental Neurology,2008,(l):226-229.
  • 4Chen Q,Andersen A H,Zhang Z,Ovadia A Gash D M Avison M J. Mapping drug-induced changes in cerebral R2* by Multiple Gradient Recalled Echo functional MRI[J].Magnetic Resonance Imaging,1996,(05):469-476.
  • 5Chin C L,Tovcimak A E,Hradil V P,Seifert T R Hollingsworth P R Chandran P Zhu C Z Gauvin D Pai M Wetter J Hsieh G C Honore P Frost J M Dart M J Meyer M D Yao B B Cox B F Fox G B. Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI[J].British Journal of Pharmacology,2008,(02):367-379.doi:10.1038/sj.bjp.0707506.
  • 6Ding F,Luan L,Ai Y,Walton A Gerhardt G A Gash D M Grondin R Zhang Z. Development of a stable,early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys[J].Experimental Neurology,2008,(02):431-439.doi:10.1016/j.expneurol.2008.04.027.
  • 7Fearnley J M,Lees A J. Ageing and Parkinson's disease:substantia nigra regional selectivity[J].Brain,1991,(05):2283-2301.
  • 8Honey G,Bullmore E. Human pharmacological MRI[J].Trends in Pharmacological Sciences,2004,(07):366-374.
  • 9Jenkins B G,Sanchez-Pernaute R,Brownell A L,Chen Y C Isacson O. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging[J].The Journal of Neuroscience,2004,(43):9553-9560.
  • 10Langston J W,Ballard P A Jr. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine[J].New England Journal of Medicine,1983,(05):310-321.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部